Quest Diagnostics Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 4/6
Quest Diagnostics verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 1.9%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 5.6%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 5.2%. Die Eigenkapitalrendite von Quest Diagnostics beträgt 13.7% und die Nettomargen betragen 9.1%.
Wichtige Informationen
1.9%
Wachstumsrate der Gewinne
5.4%
EPS-Wachstumsrate
Healthcare Wachstum der Industrie | 8.5% |
Wachstumsrate der Einnahmen | 5.2% |
Eigenkapitalrendite | 13.7% |
Netto-Marge | 9.1% |
Nächste Ertragsaktualisierung | 23 Jul 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04Quest Diagnostics declares $0.66 dividend
Nov 14Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 06Decode Health, Quest to collaborate to improve biomarker discovery for drug discovery
Oct 18Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Oct 06Quest Diagnostics to acquire select assets of Summa Health
Oct 05Aufschlüsselung der Einnahmen und Ausgaben
Wie Quest Diagnostics Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
31 Mar 24 | 9,287 | 842 | 1,621 | 0 |
31 Dec 23 | 9,252 | 850 | 1,615 | 0 |
30 Sep 23 | 9,297 | 759 | 1,748 | 0 |
30 Jun 23 | 9,488 | 790 | 1,825 | 0 |
31 Mar 23 | 9,603 | 789 | 1,832 | 0 |
31 Dec 22 | 9,883 | 942 | 1,818 | 0 |
30 Sep 22 | 10,294 | 1,230 | 1,736 | 0 |
30 Jun 22 | 10,582 | 1,479 | 1,705 | 0 |
31 Mar 22 | 10,679 | 1,874 | 1,715 | 0 |
31 Dec 21 | 10,788 | 1,988 | 1,723 | 0 |
30 Sep 21 | 11,046 | 2,175 | 1,674 | 0 |
30 Jun 21 | 11,058 | 2,238 | 1,642 | 0 |
31 Mar 21 | 10,335 | 1,794 | 1,571 | 0 |
31 Dec 20 | 9,437 | 1,425 | 1,545 | 0 |
30 Sep 20 | 8,361 | 1,101 | 1,414 | 0 |
30 Jun 20 | 7,531 | 749 | 1,378 | 0 |
31 Mar 20 | 7,657 | 771 | 1,376 | 0 |
31 Dec 19 | 7,726 | 835 | 1,457 | 0 |
30 Sep 19 | 7,639 | 709 | 1,402 | 0 |
30 Jun 19 | 7,572 | 707 | 1,406 | 0 |
31 Mar 19 | 7,538 | 720 | 1,387 | 0 |
31 Dec 18 | 7,531 | 733 | 1,395 | 0 |
30 Sep 18 | 7,557 | 860 | 1,378 | 0 |
30 Jun 18 | 7,524 | 808 | 1,359 | 0 |
31 Mar 18 | 7,469 | 782 | 1,372 | 0 |
31 Dec 17 | 7,402 | 769 | 1,421 | 0 |
30 Sep 17 | 7,398 | 671 | 1,413 | 0 |
30 Jun 17 | 7,427 | 701 | 1,480 | 0 |
31 Mar 17 | 7,469 | 702 | 1,558 | 0 |
31 Dec 16 | 7,214 | 642 | 1,337 | 0 |
30 Sep 16 | 7,503 | 675 | 1,624 | 0 |
30 Jun 16 | 7,498 | 825 | 1,637 | 0 |
31 Mar 16 | 7,517 | 748 | 1,637 | 0 |
31 Dec 15 | 7,493 | 706 | 1,616 | 0 |
30 Sep 15 | 7,527 | 703 | 1,654 | 0 |
30 Jun 15 | 7,551 | 491 | 1,657 | 0 |
31 Mar 15 | 7,528 | 507 | 1,651 | 0 |
31 Dec 14 | 7,435 | 549 | 1,635 | 0 |
30 Sep 14 | 7,308 | 506 | 1,638 | 0 |
30 Jun 14 | 7,192 | 780 | 1,620 | 0 |
31 Mar 14 | 7,105 | 799 | 1,620 | 0 |
31 Dec 13 | 7,146 | 811 | 1,632 | 0 |
30 Sep 13 | 7,164 | 809 | 1,650 | 0 |
30 Jun 13 | 7,198 | 565 | 1,623 | 0 |
Qualität der Erträge: DGX hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: DGXDie aktuellen Gewinnspannen (9.1%) sind höher als im letzten Jahr (8.2%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: DGXIn den letzten 5 Jahren sind die Gewinne von 1.9% jährlich gestiegen.
Beschleunigtes Wachstum: DGXDas Gewinnwachstum des Unternehmens im letzten Jahr (6.7%) übertrifft seinen 5-Jahres-Durchschnitt (1.9% pro Jahr).
Erträge im Vergleich zur Industrie: DGX Das Gewinnwachstum im vergangenen Jahr (6.7%) übertraf nicht die Entwicklung der Branche Healthcare 15.1% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: DGXDie Eigenkapitalrendite des Unternehmens (13.7%) wird als niedrig angesehen.